• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제21권3호
• /
• pp.155-162
• /
• 2018

Infant formula is classified into standard cow's milk-based and special formulas. This review aimed at summarizing the types of special milk formulas currently sold in Korea, and the appropriate indications for the use of these formulas; lactose free formula, soy-based formula, protein hydrolysate formula, amino acid-based formula, preterm formula, medium chain triglyceride formula, low-phosphorus formula, protein-energy-enriched formula, and formulas for inborn errors of metabolism.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제17권1호
• /
• pp.1-5
• /
• 2014

The diagnosis and treatment of cow's milk protein allergy (CMPA) is still a challenge. A systematic literature search was performed using Embase, Medline, The Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Clinical Trials for the diagnosis and treatment of cow's milk allergy (CMA). Since none of the symptoms of CMPA is specific and since there is no sensitive diagnostic test (except a challenge test), the diagnosis of CMPA remains difficult. A "symptom-based score" is useful in children with symptoms involving different organ systems. The recommended dietary treatment is an extensive cow milk based hydrolysate. Amino acid based formula is recommended in the most severe cases. However, soy infant formula and hydrolysates from other protein sources (rice) are gaining popularity, as they taste better and are cheaper than the extensive cow's milk based hydrolysates. Recent meta-analyses confirmed the safety of soy and estimate that not more than 10-15% of CMPA-infants become allergic to soy. An accurate diagnosis of CMA is still difficult. The revival of soy and the development of rice hydrolysates challenge the extensive cow's milk based extensive hydrolysates as first option and amino acid formula.

• Preventive Nutrition and Food Science
• /
• 제16권3호
• /
• pp.248-252
• /
• 2011

Soy protein based formula (SPF) has been developed for infants who are at a high risk for atopic dermatitis (AD) and cow's milk protein allergy (CMA). We performed this study to evaluate the therapeutic efficacy and safety of SPF compared to conventional hydrolyzed cow's milk formula (hCMF) in the feeding of infants with AD and CMA. 38 infants (12 to 24 months of age) diagnosed with CMA and AD were randomized to receive either SPF or hCMF for 12 weeks. Follow-up was conducted at 4, 8 and 12 weeks. Growth parameters of the infants were evaluated during each visit. Clinical evaluations, including AD severity scores, pruritus, specific immunoglobulin E (IgE) (cow's milk protein and soy protein) levels of peripheral blood, were made at enrollment and week 12. Analysis was performed on the 32 infants (SPF: n=16, hCMF: n=16) who completed the 12-week intervention. Eczema area and severity index (EASI) scores, a measure of the severity of AD, and pruritus were significantly reduced after 12 weeks compared to enrollment in the both groups; however, the median changes for EASI scores and pruritus were not statistically different between the two groups. The growth parameters did not differ significantly between both groups at any assessed time point. This study suggests that SPF could be useful in decreasing the severity of AD without affecting infant growth status. Therefore SPF could provide an adequate and safe alternative to hCMF in treating infants with AD and CMA during the first 12 to 24 months of their life.

• 대한소아치과학회지
• /
• 제25권1호
• /
• pp.93-102
• /
• 1998

Infant formula in nursing bottle, with inappropriate feeding habits, is major factor associated with the development of nursing caries. Although each infant formula has different carbohydrate and protein composition, studies comparing cariogenic potential of many Korean-branded infant formulas are deficient. In addition, it is on the point of being difficult to evaluate the cariogenecity of milk due to development of many infant formulas. In this study, to evaluate the cariogenic potential of many infant formulas, after oral rinse with six Korean-branded infant formulas(three milk based formulas, one soy based formula and two specific formulas for infants with allergy to milk protein and with lactose intolerance) for ten adult volunteers(eight males and two females), plaque pH change was measured with In vivo/In vitro combination technique and results were as follows. 1. All six different kinds of Korean-branded commercial infant formulas dropped the plaque pH significantly(p<0.05) and at an hour after rinse, plaque pH was not recovered in most of subjects. 2. Soy based infant formula and casein-hydrolyzated infant formula containing no casein dropped the plaque pH significantly more than milk based infant formula containing casein (p<0.05). 3. In the milk protein of infant formulas, casein had more effect on buffering the pH change of the infant formula than whey protein and casein-hydrolyzated infant formula had a reduced effect of casein. 4. In infant formulas with similar protein composition, infant formula containing sucrose dropped plaque pH more than infant formula containing lactose, but there was no significant difference (p>0.05).

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제12권sup1호
• /
• pp.27-36
• /
• 2009

Some pediatric patients who can not eat orally depend on enteral tube feedings, and some patients require more nutrients and calories to achieve the catch-up growth. If a patient is counting on the parenteral nutrition, early initiation of enteral feeding, orally or enterally, is a very good for the intestinal mucosal maturity and motility. There are numerous kinds of formulas and supplements for the enteral feeding for neonates, infants, and children. Depending on the intestinal symptoms, allergic symptoms, requirement of special nutrients, we can choose regular infant formula (milk-based, soy-based), protein hydrolysate formula, amino acid hydrolysate formula, elemental formula. Proper use of these formulas would help for the pediatric patients to recover from their diseases, to facilitate the intestinal mucosal maturity and to achieve their goal of growth.

• 한국식품영양과학회지
• /
• 제36권5호
• /
• pp.569-577
• /
• 2007

영 유아의 정상적인 성장과 발육에 도움을 줄 수 있는 영 유아용 조제식의 영양적 완전성을 강화하기 위하여 우리나라, CODEX, 미국, 일본, EU, 호주 및 뉴질랜드의 관련법령 및 개선안을 비교 분석 후, 우리나라 영 유아용 조제식의 규격기준의 개선방안을 다음과 같이 제시하고자 한다. 조제유류와 영아용 조제식으로 이원화된 기준을 CODEX 규격안과 같이 '영 유아용 조제식'으로 통합하고 사용 대상을 6개월 이내의 영 유아로 한정하도록 제시한다. 영 유아용 조제식의 유단백질에 대한 질소계수를 CODEX 규격안과 동일한 수준으로 변경하고, 단백질 급원에 따른 함량별 차이와 모유내의 필수아미노산 성분을 단백질 함량 규격에 제시한다. 또한 영 유아를 위한 필수지방산인 $\alpha$-linolenic acid, DHA와 EPA, trans fatty acid 함유량을 지방 함량 규격에 제시한다. 영 유아용 조제식의 비타민과 무기질 및 기타 영양소의 성분기준을 선진국과 동일한 중량(100 g)당에서 에너지(100 kcal)당 영양소 함량으로 개선하도록 제시한다. 현행 규격에는 일부 비타민(비타민 A, D)과 무기질(나트륨, 칼륨 및 염소)의 최대값만 지정되어 있으므로 모든 비타민과 무기질의 최대값을 설정하도록 제시한다. CODEX 규격안, EU, 호주 및 뉴질랜드 영 유아용 조제식 관련 규격에서 제시한 모유내 면역증진성분으로 알려진 nucleotide 5종(cytidine, uridine, adenosine, guanosine, inosine 5'-monophosphate)과 치아 건강 유지에 도움이 되는 불소의 함량 규격을 설정하도록 제시한다.